Alpha Cognition in Milano on Wednesday November 9th
Peterson Capital in collaboration with Westmount Capital will introduce next wednesday in Milan, Alpha Cognition, a Canadian clinical-stage biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases such as Alzheimer's Disease and Amyotrophic Lateral Sclerosis. ALPHA-1062 is a patented new chemical entity that has demonstrated safety and improved tolerability in human clinical trials. It is being developed as a…